Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2025-10-14 Director's Dealing
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical ASA: Mandatory notification of trade by close associates to primary insider
Director's Dealing Classification · 100% confidence The document is a notification of a share purchase by a close associate of a primary insider (Chairman of the Board). This falls under the category of 'Director's Dealing' or 'Insider Trading' notifications, which is explicitly defined as 'DIRS' in the provided filing categories.
2025-10-14 English
Observe Medical ASA: Disclosure of major shareholdings following completion of the Private Placement and Subsequent Offering
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding changes in major shareholdings following a private placement and subsequent offering. It explicitly lists shareholders who have crossed disclosure thresholds (5% and 10%) as required by the Norwegian Securities Trading Act. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-10-13 English
Observe Medical ASA: Final result of the subsequent offering and allocation of offer shares - Attachment: OMASA_PDMR_appendices_Allocation_.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons, as required by market abuse regulations (MAR). It details specific share allocations to a board member and a related investment company, including names, positions, transaction dates, volumes, and prices. This fits the definition of a Director's Dealing report.
2025-10-13 English
Observe Medical ASA: Final result of the subsequent offering and allocation of offer shares
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the final results of a 'subsequent offering' of shares, including details on subscription numbers, allocation, and gross proceeds. It details capital changes and mentions the registration of share capital increases. While it mentions director dealings, the primary purpose is the announcement of the capital raise outcome. This fits the 'Capital/Financing Update' category as it pertains to fundraising and capital structure changes.
2025-10-13 English
OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering
Share Issue/Capital Change Classification · 100% confidence The document is a stock exchange announcement regarding the preliminary results of a subsequent share offering. It details the number of shares subscribed, the expected allocation date, and the timeline for the share capital increase registration. This falls under the category of capital structure changes and financing activities, specifically related to a share offering process.
2025-10-11 English
OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering
Share Issue/Capital Change Classification · 100% confidence The document is a stock exchange announcement regarding the preliminary results of a 'subsequent offering' of shares. It details the subscription period, the number of shares subscribed, and the expected timeline for allocation and registration of the capital increase. This falls under the category of share issuance and capital changes, specifically related to a follow-on offering process.
2025-10-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.